全文获取类型
收费全文 | 347篇 |
免费 | 25篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 18篇 |
妇产科学 | 18篇 |
基础医学 | 42篇 |
口腔科学 | 9篇 |
临床医学 | 36篇 |
内科学 | 77篇 |
皮肤病学 | 4篇 |
神经病学 | 27篇 |
特种医学 | 9篇 |
外科学 | 49篇 |
综合类 | 2篇 |
预防医学 | 20篇 |
眼科学 | 8篇 |
药学 | 31篇 |
中国医学 | 2篇 |
肿瘤学 | 22篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 4篇 |
2020年 | 6篇 |
2019年 | 6篇 |
2018年 | 11篇 |
2017年 | 3篇 |
2016年 | 9篇 |
2015年 | 10篇 |
2014年 | 14篇 |
2013年 | 14篇 |
2012年 | 20篇 |
2011年 | 21篇 |
2010年 | 15篇 |
2009年 | 16篇 |
2008年 | 28篇 |
2007年 | 26篇 |
2006年 | 23篇 |
2005年 | 26篇 |
2004年 | 23篇 |
2003年 | 17篇 |
2002年 | 9篇 |
2001年 | 5篇 |
2000年 | 3篇 |
1999年 | 9篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1974年 | 1篇 |
1973年 | 4篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 4篇 |
1969年 | 4篇 |
1968年 | 2篇 |
1967年 | 1篇 |
1965年 | 2篇 |
排序方式: 共有374条查询结果,搜索用时 9 毫秒
171.
Kolibianakis E Zikopoulos K Camus M Tournaye H Van Steirteghem A Devroey P 《Human reproduction (Oxford, England)》2004,19(11):2545-2549
BACKGROUND: The purpose of this study was to evaluate the use of the modified natural cycle (MNC) for IVF in poor responders as a last resort prior to oocyte donation. METHODS: Thirty-two patients with a regular menstrual cycle, FSH levels on day 3 of the cycle >12 IU/l and one or more failed IVF cycles with five or fewer cumulus-oocyte complexes (COCs) retrieved were included in this prospective study. Recombinant FSH 100 IU and GnRH antagonist 0.25 mg/day were started concomitantly when a follicle with a mean diameter of 14 mm was present at ultrasound. HCG 10 000 IU was administered as soon as the mean follicular diameter was > or =16 mm. RESULTS: Twenty-five out of 78 cycles performed (32.1%) did not result in oocyte retrieval. In nine out of 53 cycles (16.9%) in which oocyte retrieval was performed, no COCs were retrieved. Following fertilization, embryo transfer was performed in 19 out of 44 cycles in which COCs were retrieved (43.2%). No ongoing pregnancy was achieved in 78 MNCs (0.0%; 95% confidence interval 0.0-4.7). CONCLUSIONS: MNC does not offer a realistic chance of parenthood in patients with high levels of FSH on day 3 of the cycle and previous poor response to ovarian stimulation, when offered as a last resort prior to oocyte donation. 相似文献
172.
Multiplex PCR for diagnosis of enteric infections associated with diarrheagenic Escherichia coli 总被引:1,自引:0,他引:1 下载免费PDF全文
A multiplex PCR for detection of three categories of diarrheagenic Escherichia coli was developed. With this method, enterohemorrhagic E. coli, enteropathogenic E. coli, and enterotoxigenic E. coli were identified in fecal samples from patients with hemorrhagic colitis, watery diarrhea, or hemolytic-uremic syndrome and from food-borne outbreaks. 相似文献
173.
174.
Rivera P Orio M Hinostroza J Venegas P Pastor P Gorena M Lagos M Pinochet R 《Actas urologicas espa?olas》1999,23(9):757-762
We studied 67 patients with bladder cancer in stage T1, with terminated BCG treatment and in pursuit. No stage Ta neither carcinoma in situ was included. The protocol was: beginning of treatment upon retiring vesical catheter, instilation of 1 mg of liofilized BCG vaccine (16 x 10(6) bacilles) in 40-50 ml of intravesical saline solution. A weekly instilation during the first month. An instilation each 15 days during the second and third month and one monthly until complete 12 months of treatment. Also was carried out an study of T lymphocites and cytokines. RESULTS: The average followup of the 67 patients treated was 51.3 months. 17 patients relapses (25.4%). A 33% were grade 3 and 27% grade 2. Like complications there was a case of inguinal TBC adenititis, 2 TBC prostatitis, 2 TBC cistitis and 5 cases of slight disuric syndrome. The study of subpopulations of lymphocites in peripheral blood demonstrated a significant increase of CD3 and CD4/CD8 ratio. The interleukin 2 measurement in serum also increased significantly after the BCG instilations. CONCLUSIONS: Our protocol gets similar results to the higher doses, but with minimal complications diminishing the relapses of the tumors in stage T1. A monthly maintenance dose would help to maintain immunity. 相似文献
175.
Joana Franco Lacerda Ana Catarina Lagos Elisabete Carolino Ana Santos Silva-Herdade Manuel Silva Catarina Sousa Guerreiro 《Nutrients》2021,13(2)
Inflammatory bowel diseases (IBD) are characterized by a chronic inflammatory process that affects the intestinal barrier structure. Recent evidence suggests that some food components can influence the integrity of the intestinal barrier and thus its permeability. We aimed at assessing the effect of food components on the intestinal permeability (IP) and on inflammatory markers in individuals with IBD by a single-blind randomized clinical study. Of the 53 individuals included, 47% (n = 25) had been diagnosed with IBD. The participants were divided into 4 groups. IBD patients were allocated to intervention group (n = 14) vs. no intervention group (n = 11), and the same happened with 28 control participants without disease (n = 14 in intervention group vs. n = 14 without intervention). Symptomatology, nutritional status, biochemical parameters (specifically serum zonulin (ZO) to measure IP) were evaluated on all individuals on an eight week period following a diet plan with/without potentially beneficial foods for the IP. At the beginning of the study, there were no significant differences in ZO values between individuals with and without IBD (p > 0.05). The effect of specific food components was inconclusive; however, a trend in the reduction of inflammatory parameters and on the prevalence of gastrointestinal symptomatology was observed. More controlled intervention studies with diet plans, including food components potentially beneficial for the integrity of the intestinal barrier, are of the utmost importance. 相似文献
176.
177.
Thomas P. Thomopoulos Margherita Rosati Evangelos Terpos Dimitris Stellas Xintao Hu Sevasti Karaliota Anthi Bouchla Ioannis Katagas Anastasia Antoniadou Andreas Mentis Sotirios G. Papageorgiou Marianna Politou Jenifer Bear Duncan Donohue Anastasia Kotanidou Ioannis Kalomenidis Eleni Korompoki Robert Burns Maria Pagoni Elisavet Grouzi Stavroula Labropoulou Kostantinos Stamoulis Aristotelis Bamias Sotirios Tsiodras Meletios-Athanasios Dimopoulos George N. Pavlakis Vasiliki Pappa Barbara K. Felber 《Viruses》2021,13(9)
COVID-19 is an ongoing pandemic with high morbidity and mortality. Despite meticulous research, only dexamethasone has shown consistent mortality reduction. Convalescent plasma (CP) infusion might also develop into a safe and effective treatment modality on the basis of recent studies and meta-analyses; however, little is known regarding the kinetics of antibodies in CP recipients. To evaluate the kinetics, we followed 31 CP recipients longitudinally enrolled at a median of 3 days post symptom onset for changes in binding and neutralizing antibody titers and viral loads. Antibodies against the complete trimeric Spike protein and the receptor-binding domain (Spike-RBD), as well as against the complete Nucleocapsid protein and the RNA binding domain (N-RBD) were determined at baseline and weekly following CP infusion. Neutralizing antibody (pseudotype NAb) titers were determined at the same time points. Viral loads were determined semi-quantitatively by SARS-CoV-2 PCR. Patients with low humoral responses at entry showed a robust increase of antibodies to all SARS-CoV-2 proteins and Nab, reaching peak levels within 2 weeks. The rapid increase in binding and neutralizing antibodies was paralleled by a concomitant clearance of the virus within the same timeframe. Patients with high humoral responses at entry demonstrated low or no further increases; however, virus clearance followed the same trajectory as in patients with low antibody response at baseline. Together, the sequential immunological and virological analysis of this well-defined cohort of patients early in infection shows the presence of high levels of binding and neutralizing antibodies and potent clearance of the virus. 相似文献
178.
Michael I. Koukourakis M.D. Alexandra Giatromanolaki M.D. Pelagia Tsoutsou M.D. Nikolaos Lyratzopoulos M.D. Michael Pitiakoudis M.D. George Kouklakis M.D. Pelagia A. Chloropoulou M.D. Kostantinos Manolas M.D. Efthimios Sivridis M.D. 《International journal of radiation oncology, biology, physics》2011,80(2):615
179.
180.
Odisseas Gregoriou Kostantinos Papadias Sokratis Konidaris Kostantina Bakalianou Nikolaos Salakos 《Gynecological endocrinology》2013,29(4):220-223
The aim of the present study was to evaluate the biochemical and clinical effects of the combined pill consisting of ethinyl estradiol (EE) and drospirenone (DRSP) in hirsute patients. Fifty-two adolescents or young women from Greece were treated with 30 μg EE and 3 mg DRSP for 1 year. Hirsutism was evaluated by the Ferriman–Gallway (FG) score in the initial visit and at 3, 6 and 12 months. Follicle-stimulating hormone, luteinizing hormone, etradiol, free and total testosterone (T), sex hormone-binding globulin (SHBG), androstenedione and dehydroepiandrosterone sulfate were determined at the same intervals. Hirsutism improved and FG scores reduced to 77.4%, 67.2% and 51.8% at 3, 6 and 12 months, respectively. Plasma SHBG levels rose, while free and total T levels reduced from the third month onwards. In conclusion, the EE/DRSP pill improves hirsutism in women via antiandrogenic and antimineralocorticoid action. The biochemical manifestations of hyperandrogenism are also improved. 相似文献